Citigroup’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
5,643
+5,066
| +878% | +$247K | ﹤0.01% | 3205 |
|
|
2025
Q1 | $12.4K | Sell |
577
-7,007
| -92% | -$151K | ﹤0.01% | 4387 |
|
|
2024
Q4 | $204K | Buy |
+7,584
| New | +$204K | ﹤0.01% | 3572 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$8K | – | 5031 |
|
|
2021
Q2 | $8K | Sell |
200
-129
| -39% | -$5.16K | ﹤0.01% | 5054 |
|
|
2021
Q1 | $18K | Sell |
329
-200
| -38% | -$10.9K | ﹤0.01% | 4640 |
|
|
2020
Q4 | $21K | Buy |
529
+244
| +86% | +$9.69K | ﹤0.01% | 4590 |
|
|
2020
Q3 | $16K | Sell |
285
-137
| -32% | -$7.69K | ﹤0.01% | 4059 |
|
|
2020
Q2 | $31K | Buy |
422
+111
| +36% | +$8.15K | ﹤0.01% | 3980 |
|
|
2020
Q1 | $15K | Buy |
311
+111
| +56% | +$5.35K | ﹤0.01% | 4480 |
|
|
2019
Q4 | $15K | Hold |
200
| – | – | ﹤0.01% | 4585 |
|
|
2019
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 4642 |
|
|
2019
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 4814 |
|
|
2019
Q1 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 4722 |
|
|
2017
Q2 | – | Sell |
-8
| Closed | -$1K | – | 4870 |
|
|
2017
Q1 | $1K | Sell |
8
-105
| -93% | -$13.1K | ﹤0.01% | 4700 |
|
|
2016
Q4 | $23K | Buy |
113
+53
| +88% | +$10.8K | ﹤0.01% | 4346 |
|
|
2016
Q3 | $14K | Hold |
60
| – | – | ﹤0.01% | 4312 |
|
|
2016
Q2 | $12K | Sell |
60
-201
| -77% | -$40.2K | ﹤0.01% | 4423 |
|
|
2016
Q1 | $67K | Buy |
261
+188
| +258% | +$48.3K | ﹤0.01% | 4144 |
|
|
2015
Q4 | $25K | Buy |
+73
| New | +$25K | ﹤0.01% | 4423 |
|
|
2015
Q3 | – | Sell |
-6
| Closed | -$2K | – | 5236 |
|
|
2015
Q2 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 5156 |
|